MedTrace Logo

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-02-04

No results posted yet for this study

Summary

This is a purely retrospective and observational monocentric study

Conditions

  • Marginal Zone B Cell Lymphoma

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Pier Luigi Zinzani, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06806488 on ClinicalTrials.gov